EUVIMEDEUVIMED entdecken
Crossref

IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820‐encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer

Jinrong Zhou, Lixia Yao, Yuan Su, Lili Tian

Chemical Biology & Drug Design · 2024-02 · 103 (2)

DOI: 10.1111/cbdd.14473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 20.02.2024. Verfasst von Jinrong Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, People's Hospital of Dongxihu District, Wuhan, China. Hauptthemen laut MEDLINE: MicroRNAs, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: The Wuhan Medical Research Project of Hubei Province (No. WX20B18).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N6‐methyladenosine (m6A) modification and m6A‐related RNA‐binding proteins (RBPs) play vital roles in various aspects of circRNA metabolism. Hsa_circRNA_103820 is implicated in the pathogenesis of multiple cancers, including lung cancer (LC). Moreover, bioinformatics analysis has suggested that hsa_circRNA_103820 possesses potential peptide‐coding ability. Thus, we aimed to investigate the function and peptide‐coding potential of hsa_circRNA_103820 in this study. Cell viability, apoptosis rate, and migratory and invasive abilities were assessed using CCK‐8, flow cytometry, and transwell assays, respectively. Hsa_circRNA_103820 level was measured using RT‐qPCR assay, and the interaction between hsa_circRNA_103820 and IGF2BP3 was examined through RIP and RT‐qPCR assays. The coding ability of hsa_circRNA_103820 and protein levels were determined through western blot assay. The results showed that hsa_circRNA_103820 reduced cell viability, attenuated cell migratory and invasive abilities, and promoted cell apoptosis in LC. IGF2BP3 negatively regulated hsa_circRNA_103820 expression and interacted with it. Hsa_circRNA_103820 knockdown alleviated si‐IGF2BP3‐mediated anti‐viability, anti‐migration, anti‐invasion, and pro‐apoptosis effects in LC cells. Moreover, a 188‐amino acid (aa) peptide encoded by hsa_circRNA_103820 decreased cell viability, facilitated cell apoptosis, and inhibited cell migration and invasion in LC. Collectively, hsa_circRNA_103820, regulated by IGF2BP3, encodes a 188‐aa peptide and inhibits the malignant progression of LC cells by inhibiting the AKT pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsLung NeoplasmsHumansRNA, CircularProto-Oncogene Proteins c-aktCell ProliferationPeptidesCell Line, TumorCell Movement

Stichwörter der Autor:innen

AKTIGF2BP3hsa_circRNA_103820lung cancerpeptide

Substanzen

RNA, CircularMicroRNAsProto-Oncogene Proteins c-aktPeptides

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, People's Hospital of Dongxihu District, Wuhan, China.
  • Department of Respiratory and Critical Care Medicine, Union Hospital affiliated to Huazhong University of Science and Technology, Wuhan, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China.

Förderung

  • The Wuhan Medical Research Project of Hubei Province (No. WX20B18)

Zitieren

APA

Zhou, J., Yao, L., Su, Y., & Tian, L. (2024). IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820‐encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer. Chemical Biology & Drug Design, 103(2). https://doi.org/10.1111/cbdd.14473

Vancouver

Zhou J, Yao L, Su Y, Tian L. IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820‐encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer. Chemical Biology & Drug Design. 2024;103(2). doi:10.1111/cbdd.14473

BibTeX
@article{Zhou2024,
  author = {Zhou, Jinrong and Yao, Lixia and Su, Yuan and Tian, Lili},
  title = {IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820‐encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  volume = {103},
  number = {2},
  doi = {10.1111/cbdd.14473}
}
Kostenlos starten →